![Factors responsible for long-term survival in metastatic breast cancer | World Journal of Surgical Oncology | Full Text Factors responsible for long-term survival in metastatic breast cancer | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1477-7819-12-344/MediaObjects/12957_2014_Article_1805_Fig3_HTML.jpg)
Factors responsible for long-term survival in metastatic breast cancer | World Journal of Surgical Oncology | Full Text
![Frontiers | The Emerging Role of Tissue-Resident Memory CD8+ T Lymphocytes in Human Digestive Tract Cancers Frontiers | The Emerging Role of Tissue-Resident Memory CD8+ T Lymphocytes in Human Digestive Tract Cancers](https://www.frontiersin.org/files/Articles/819505/fonc-11-819505-HTML-r1/image_m/fonc-11-819505-g001.jpg)
Frontiers | The Emerging Role of Tissue-Resident Memory CD8+ T Lymphocytes in Human Digestive Tract Cancers
Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular C
![Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study](https://www.frontiersin.org/files/Articles/858202/fonc-12-858202-HTML/image_m/fonc-12-858202-g001.jpg)
Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study
![The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis - eClinicalMedicine The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/attachment/682ac112-4688-4fef-8fe2-173a8219b81a/gr1.jpg)
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis - eClinicalMedicine
![Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/3c519893-23a9-4078-946a-1fd1e40feff8/gr3.jpg)
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology
![IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML](https://www.mdpi.com/ijms/ijms-23-06994/article_deploy/html/images/ijms-23-06994-g004.png)
IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML
![Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis - Sidana - 2019 - American Journal of Hematology - Wiley Online Library Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis - Sidana - 2019 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/eeac55fc-029c-4cd9-acea-433d4ea6ce68/ajh25566-fig-0001-m.jpg)
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis - Sidana - 2019 - American Journal of Hematology - Wiley Online Library
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia | Haematologica
![IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML](https://www.mdpi.com/ijms/ijms-23-06994/article_deploy/html/images/ijms-23-06994-g001.png)
IJMS | Free Full-Text | An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer | HTML
![Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome - Biology of Blood and Marrow Transplantation Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/62be1a5b-cf36-49da-a2af-0a1c33a96a80/gr4_lrg.jpg)
Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome - Biology of Blood and Marrow Transplantation
![Highly Prolonged Overall Survival Following Reduced Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma in the New Drugs Era - Clinical Lymphoma, Myeloma and Leukemia Highly Prolonged Overall Survival Following Reduced Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma in the New Drugs Era - Clinical Lymphoma, Myeloma and Leukemia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2037463060/2051918605/fx1.jpg)
Highly Prolonged Overall Survival Following Reduced Intensity Allogeneic Stem Cell Transplantation for Multiple Myeloma in the New Drugs Era - Clinical Lymphoma, Myeloma and Leukemia
![Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram](https://www.researchgate.net/publication/237097399/figure/fig3/AS:669276801351688@1536579432420/Three-year-probability-of-overall-survival-OS-disease-free-survival-DFS.png)
Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram
![Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101) Post-Transplant Results in Decreased Transplant-Related Mortality and Improved Survival in Acute Leukemia Patients Undergoing T-Depleted Haploidentical Stem Cell Transplantation ... Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101) Post-Transplant Results in Decreased Transplant-Related Mortality and Improved Survival in Acute Leukemia Patients Undergoing T-Depleted Haploidentical Stem Cell Transplantation ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2053935579/2060401307/jcyt636-fig-0003.jpg)
Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101) Post-Transplant Results in Decreased Transplant-Related Mortality and Improved Survival in Acute Leukemia Patients Undergoing T-Depleted Haploidentical Stem Cell Transplantation ...
![Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts - Huang - Translational Pediatrics Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts - Huang - Translational Pediatrics](https://cdn.amegroups.cn/journals/amepc/files/journals/6/articles/72345/public/72345-PB6-1589-R1.png/w300)
Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts - Huang - Translational Pediatrics
![Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/10/4/e003472/F3.large.jpg)
Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time? | Journal for ImmunoTherapy of Cancer
![Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants - Biology of Blood and Marrow Transplantation Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants - Biology of Blood and Marrow Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0da04648-7c6b-4528-8617-4b055f27c369/gr1.jpg)
Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants - Biology of Blood and Marrow Transplantation
![Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission | Bone Marrow Transplantation Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41409-020-0936-z/MediaObjects/41409_2020_936_Fig1_HTML.png)
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission | Bone Marrow Transplantation
![Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia - ScienceDirect Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2341287922000771-gr1.jpg)
Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia - ScienceDirect
![Figure 1 | Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies | SpringerLink Figure 1 | Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies | SpringerLink](https://media.springernature.com/full/springer-static/image/art%3A10.1007%2Fs00277-019-03884-8/MediaObjects/277_2019_3884_Fig1_HTML.png)
Figure 1 | Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies | SpringerLink
![Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology](https://www.jto.org/cms/asset/3b4b3b7f-ef3e-49b2-b1e3-89793b6a8627/gr1.jpg)
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology
![Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-022-04817-8/MediaObjects/277_2022_4817_Fig4_HTML.png)
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink
![Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer | Communications Biology Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer | Communications Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs42003-021-02595-z/MediaObjects/42003_2021_2595_Fig3_HTML.png)